About us

• Building a profitable and cash generative business
• Developing and commercialising low-risk late stage products for unmet medical need
• Partnering all of our drug candidates; selective investment in our in-house products
• Highly experienced executive and senior management team

One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Our pipeline reflects our strategy and is split between our later stage commercial pipeline and our NCE portfolio.